Zhipeng Su

1.7k total citations
76 papers, 1.3k citations indexed

About

Zhipeng Su is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Zhipeng Su has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Immunology. Recurrent topics in Zhipeng Su's work include Pituitary Gland Disorders and Treatments (15 papers), Glioma Diagnosis and Treatment (7 papers) and Adrenal and Paraganglionic Tumors (5 papers). Zhipeng Su is often cited by papers focused on Pituitary Gland Disorders and Treatments (15 papers), Glioma Diagnosis and Treatment (7 papers) and Adrenal and Paraganglionic Tumors (5 papers). Zhipeng Su collaborates with scholars based in China, United States and Hong Kong. Zhipeng Su's co-authors include Kevin D. Burns, Chengde Wang, Lin Cai, Weiming Zheng, Qun Li, Fansheng Kong, Jianglong Lu, Zhe Wu, Liang Feng and Yuting Liao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Food Chemistry.

In The Last Decade

Zhipeng Su

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhipeng Su China 19 622 250 206 199 140 76 1.3k
Weitao Cong China 24 1.0k 1.6× 179 0.7× 127 0.6× 108 0.5× 138 1.0× 79 1.8k
Elena Donetti Italy 22 789 1.3× 200 0.8× 265 1.3× 138 0.7× 197 1.4× 74 1.9k
Masoud Darabi Iran 24 617 1.0× 284 1.1× 177 0.9× 89 0.4× 133 0.9× 108 1.8k
Thangirala Sudha United States 23 655 1.1× 177 0.7× 149 0.7× 111 0.6× 56 0.4× 46 1.2k
Wenjun Yang China 24 696 1.1× 245 1.0× 118 0.6× 114 0.6× 44 0.3× 64 1.5k
Hui Guan China 22 706 1.1× 189 0.8× 139 0.7× 85 0.4× 79 0.6× 66 1.5k
Chunyang Du China 22 900 1.4× 156 0.6× 215 1.0× 118 0.6× 46 0.3× 41 1.8k
Manish Jain India 26 501 0.8× 181 0.7× 365 1.8× 82 0.4× 179 1.3× 104 1.8k
Valerio Izzi Finland 22 706 1.1× 198 0.8× 205 1.0× 45 0.2× 71 0.5× 59 1.5k
Jacob Grünler Sweden 18 929 1.5× 284 1.1× 85 0.4× 245 1.2× 35 0.3× 27 1.7k

Countries citing papers authored by Zhipeng Su

Since Specialization
Citations

This map shows the geographic impact of Zhipeng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Su more than expected).

Fields of papers citing papers by Zhipeng Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhipeng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Su. The network helps show where Zhipeng Su may publish in the future.

Co-authorship network of co-authors of Zhipeng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zhipeng Su. A scholar is included among the top collaborators of Zhipeng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhipeng Su. Zhipeng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Shuangshuang, Zhipeng Gao, Zhipeng Su, et al.. (2025). Redox-responsive self-assembled HG-type pectin nanomicelles for alleviating chronic alcoholic liver injury in mice. Carbohydrate Polymers. 361. 123619–123619. 1 indexed citations
2.
Xu, Shihao, et al.. (2025). Diabetes mellitus exacerbates changes in white matter hyperintensity shapes and volume: A longitudinal study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(1). e70042–e70042. 3 indexed citations
3.
Gao, Zhipeng, Donglin Su, Zhipeng Su, et al.. (2025). Facile and green synthesis of nanocarriers from chondroitin sulfate-based and whey protein isolate with improved stability and biocompatibility for anthocyanins protection. Food Chemistry. 476. 143449–143449. 3 indexed citations
4.
Yao, Feng, Yanting Liu, Yong Zhang, et al.. (2024). Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis. International Immunopharmacology. 134. 112159–112159. 7 indexed citations
5.
Su, Zhipeng, et al.. (2024). Modeling and health feature extraction method for lithium-ion batteries state of health estimation by distribution of relaxation times. Journal of Energy Storage. 90. 111770–111770. 11 indexed citations
6.
Li, Jizhen, Lingling Zhao, Shirui Huang, et al.. (2024). SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4. Journal of Experimental & Clinical Cancer Research. 43(1). 231–231. 4 indexed citations
7.
Huang, Jing, et al.. (2024). ZBP1 condensate formation synergizes Z-NAs recognition and signal transduction. Cell Death and Disease. 15(7). 487–487. 13 indexed citations
8.
Cai, Lin, Lei Cao, Jianglong Lu, et al.. (2022). ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathway. Acta Pharmacologica Sinica. 43(9). 2386–2396. 9 indexed citations
9.
Lu, Jianglong, et al.. (2022). A Multielement Prognostic Nomogram Based on a Peripheral Blood Test, Conventional MRI and Clinical Factors for Glioblastoma. Frontiers in Neurology. 13. 822735–822735. 9 indexed citations
10.
Gao, Wenqing, Teng Zhang, Jianglong Lu, et al.. (2022). Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma. Journal of Inflammation Research. Volume 15. 2731–2743. 13 indexed citations
11.
Su, Zhipeng, Ningning Zhou, Fugen Shangguan, et al.. (2021). Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling. Cell Death and Disease. 12(3). 251–251. 24 indexed citations
12.
Su, Zhipeng, et al.. (2018). Anti-MET VHH Pool Overcomes MET-Targeted Cancer Therapeutic Resistance. Molecular Cancer Therapeutics. 18(1). 100–111. 17 indexed citations
13.
Lu, Jianglong, Qun Li, Lin Cai, et al.. (2018). RBM17 controls apoptosis and proliferation to promote Glioma progression. Biochemical and Biophysical Research Communications. 505(1). 20–28. 12 indexed citations
14.
Su, Zhipeng, et al.. (2017). MicroRNA-342 inhibits the progression of glioma by directly targeting PAK4. Oncology Reports. 38(2). 1240–1250. 14 indexed citations
15.
Zhu, Jiawen, Téngfēi Zhāng, Zhipeng Su, et al.. (2016). (p)ppGpp synthetases regulate the pathogenesis of zoonotic Streptococcus suis. Microbiological Research. 191. 1–11. 18 indexed citations
16.
Zeng, Bo, Danhua Zhu, Zhipeng Su, Zequn Li, & Zhengquan Yu. (2016). Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13. International Immunopharmacology. 39. 63–70. 14 indexed citations
17.
Li, Lu, Zhaohui Chen, Weicheng Bei, et al.. (2015). Catecholamines Promote Actinobacillus pleuropneumoniae Growth by Regulating Iron Metabolism. PLoS ONE. 10(4). e0121887–e0121887. 17 indexed citations
18.
Su, Zhipeng, Xiaolong Jiang, Chengde Wang, et al.. (2012). Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells. Endocrine. 42(3). 670–675. 8 indexed citations
19.
Su, Zhipeng, Jing Zhang, Zhe Wu, et al.. (2010). Killing effect of interleukin-13 receptor alpha 2 (IL-13Rα2) sensitized DC–CTL cells on human glioblastoma U251 cells. Cellular Immunology. 263(2). 172–175. 11 indexed citations
20.
Su, Zhipeng, et al.. (2006). Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney International. 69(12). 2212–2218. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weitao Cong Breakdown of academic impact, for papers by Elena Donetti Breakdown of academic impact, for papers by Masoud Darabi Breakdown of academic impact, for papers by Thangirala Sudha Breakdown of academic impact, for papers by Wenjun Yang Breakdown of academic impact, for papers by Hui Guan Breakdown of academic impact, for papers by Chunyang Du Breakdown of academic impact, for papers by Manish Jain Breakdown of academic impact, for papers by Valerio Izzi Breakdown of academic impact, for papers by Jacob Grünler
Rankless by CCL
2026